Kadimastem Competitors and Similar CompaniesClear all
Kadimastem's competitors and similar companies include Antag Therapeutics, Enthera Pharmaceuticals, Hua Medicine and Follicum.
 Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). |  Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. | |||
Founding Date | Founding Date 2009 | Founding Date 2017 | Founding Date 2016 | Founding Date 2011 | Founding Date 2011 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Ness Ziona, IL HQ | Locations København, DK HQ | Locations Milan, IT HQ Milan, IT Milan, IT | Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK | Locations Lund, SE HQ |
Employees | Employees 11 | Employees 20 | Employees 225% increase | Employees 168 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥492.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥180.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit (kr13.1m) (FY, 2021) | Gross profit N/A | Gross profit ¥1.6b (FY, 2025) | Gross profit kr357k (FY, 2021) |
Net income | Net income (₪26.6m) (FY, 2024) | Net income (kr14.9m) (FY, 2021) | Net income N/A | Net income ¥1.1b (FY, 2025) | Net income (kr24.2m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 32.8m | Total funding raised $ 242.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Antag Therapeutics
HQ
København, DK
Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View company
Hua Medicine
HQ
Shanghai, CN
Employees
168
Hua Medicine (华领医药) is a drug development company.
View company
Follicum
HQ
Lund, SE
Follicum is a company focused on the stimulation of hair growth and diabetes.
View company